Debate Series - Estro-events.org
Debate Series - Estro-events.org
Debate Series - Estro-events.org
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
E-posTErs<br />
E-Posters<br />
CliniCal inTERdiSCiPlinaRy PhySiCS RadiObiOlOgy RTT yOung<br />
Page 266 PROgRammE & ExhibiTiOn guidE • ESTRO 31<br />
abS. numbER<br />
> Incidence of toxicity in locally advanced head ? Neck cancer pts<br />
(LAHNSCC) treated with cetuximab plus radiotherapy<br />
I. Prieto (Spain), C. Díaz, J. Pardo, J. Luna, A.M. Pérez Casas EP-1163<br />
> Fixed field IMRT, VMAT and tomotherapy techniques for HNSCC:<br />
a dosimetric and volumetric comparison<br />
R. Lynn (United Kingdom), N. Walsh, M. Lei, K. Applegate,<br />
D. Convery, T. Guerrero-Urbano EP-1164<br />
> Incidence of synchronous bilateral tonsillar squamous cell carcinoma<br />
B.A. Wysocka (Denmark), B.P. Ulhøi, U. Pedersen, C. Grau EP-1165<br />
> Head and neck cancer intensity modulated radiotherapy: parotid<br />
glands volumetric changes<br />
A. Fiorentino (Italy), C. Chiumento, R. Caivano, V. Metallo,<br />
M. Cozzolino, S. Clemente, P. Pedicini, V. Fusco EP-1166<br />
> Postoperative intensity modulated radiotherapy in high risk or<br />
locally advanced oral cavity cancer<br />
P. Ghadjar (Switzerland), B. Bojaxihu, A. Arnold, W. Hallermann,<br />
D.M. Aebersold, A. Geretschläger EP-1167<br />
> Reirradiation for recurrent head and neck carcinoma<br />
E. Peponi (Greece), I. Tasiou, S. Balta, P. Gogou, A. Capizzello,<br />
E. Pitouli, P. Tsekeris EP-1168<br />
> Parotid gland cancer: review of cases treated with radiotherapy at<br />
our center<br />
M. Altabas (Spain), S. Benavente, C. Bescos, J. Pamias, D. Malet,<br />
J.M. del Campo, J. Giralt EP-1169<br />
> PET-TC planning in head and neck cancer- our experience<br />
E. Jurado Martín (Spain), G. Ossola, R. Mendoza, C. Lainez,<br />
S. Perez, M.V. Lasa, P. SanAgustin, C. Galan EP-1170<br />
E-Posters<br />
abS. numbER<br />
> Supraglottic laryngeal carcinomas: tight margin has beneficial<br />
effect for reducing late toxicity<br />
C.A.J.M. Vugts (The Netherlands), C.H.J. Terhaard,<br />
M.E.P. Philippens, C.P.J. Raaijmakers EP-1171<br />
> Percentage of head and neck cancer patients for which IMRT is<br />
desirable due to dose coverage to gross tumor volume<br />
T. Toyoda (Japan), A. Terahara, K. Nakagawa, K. Ohtomo,<br />
T. Machida EP-1172<br />
> Impact of PET-CT in the treatment of locally advanced head and<br />
neck (H&N) cancer<br />
V. Chicata Sutmöller (Spain), C. Eito Valdovinos, F. Arias de la Vega,<br />
G. Asín Felipe, M. Rico Osés, M. Errasti, M.A. Domínguez Domínguez EP-1173<br />
> Clinico-pathological patterns and survival outcome of malignant<br />
tumors of major salivary glands<br />
A. Jamshed (Pakistan), R. Hussain, H. Iqbal, K. Saeed, T. Sadaf,<br />
T. Mehmood, A. Loya EP-1174<br />
> Hypofractionated palliative radiotherapy for advanced head and<br />
neck cancer: the IHF2SQ regimen<br />
L. Monnier (France), E. Touboul, C. Durdux, P. Lang,<br />
J. Lacau St Guily, F. Huguet EP-1175<br />
> Proton beam therapy for patients with stage T4 and/or N3 nasopharyngeal<br />
carcinoma<br />
C. Makita (Japan), T. Nakamura, A. Takada, K. Takayama,<br />
T. Katou, N. Fuwa EP-1176<br />
> IMRT for head & neck cancer - is there a correlation between mean<br />
contralateral parotid dose and late oral toxicity?<br />
M. Thomson (United Kingdom), D. McIntosh, C. Paterson,<br />
A. James, B. Clark, D. Grose EP-1177<br />
ESTRO 31 • PROgRammE & ExhibiTiOn guidE Page 267<br />
E-posTErs<br />
eSTRO 31
Change language